Dr. Robert Sutherland, PhD
Imaging and treatment
Vice-President, Commercialization for the Ontario Institute for Cancer Research (OICR)
Dr. Robert Sutherland is developing OICR’s commercialization program including intellectual property management, identification of projects for early stage development and the engagement of market receptors and investor groups. Most recently, Dr. Sutherland was President of Varian Biosynergy, a subsidiary of Varian Medical Systems in Palo Alto, California from 1995 to 2006. The focus of Dr. Sutherland's research career has been on the design of cancer therapies and the mechanisms of resistance of cancer to therapy. He was recently a Consulting Professor of Radiation Oncology at Stanford University and is currently a member of several academic advisory groups and industry boards.
